TY  - CONF

T1  - Cathepsin K inhibitors for treating cancer-induced bone disease

JO  - CLINICAL & EXPERIMENTAL METASTASIS

PY  - 2008/01/01

AU  - Clezardin P

ED  - 

VL  - 25

SP  - 15

EP  - 15

Y2  - 2025/10/26

ER  -